Female Breast Cancer and Alcohol Consumption A Review of the Literature by Scoccianti, Chiara et al.
Female Breast Cancer and Alcohol Consumption
A Review of the Literature
Chiara Scoccianti, PhD, Béatrice Lauby-Secretan, PhD, Pierre-Yves Bello, MD, MPH,
Véronique Chajes, PhD, Isabelle Romieu, MD, MPH, ScDFrom the Nut
IARC Monog
Agency for Re
General Direct
Address co
Section of Nut
Cancer, 150 C
romieui@iarc.f
0749-3797/
http://dx.do
S16 Am J PContext: Consumption of alcoholic beverages is one of the single most important known and
modiﬁable risk factor for human cancer. Among women, breast cancer is the most common cancer
worldwide and the leading cause of cancer-related mortality. Consumption of alcoholic beverages is
causally associated with female breast cancer and the association shows a linear dose–response
relationship. The role of heavy drinking has been long recognized and even a moderate intake is
associated with an increased risk for breast cancer. The present review is an update of the current
evidence on the association between alcohol consumption and breast cancer risk. The aim is to gain
further insight into this association and to improve our current understanding of the effects of the
major modifying factors.
Evidence acquisition: Epidemiologic and experimental studies published since the most recent
International Agency for Research on Cancer (IARC) Monograph on alcoholic beverages were
identiﬁed in PubMed using a combination of keywords such as alcohol, breast cancer, poly-
morphisms, menopausal status.
Evidence synthesis: Cumulative lifetime consumption, drinking frequency, drinking patterns and
timing of exposure each modulate the association between alcohol consumption and breast cancer.
Hormonal status, genetic polymorphisms, and nutritional factors may interact with ethanol
metabolism and further inﬂuence breast cancer risk.
Conclusions: Better standardization among experimental and epidemiologic designs in assessing
alcohol intake and timing of exposure may improve our understanding of the heterogeneity
observed across studies, possibly allowing the quantiﬁcation of the effects of occasional heavy
drinking and the identiﬁcation of a window of higher susceptibility to breast cancer development.
(Am J Prev Med 2014;46(3S1):S16–S25) & 2014 Published by Elsevier Inc. on behalf of American Journal of
Preventive Medicine Open access under CC BY-NC-ND license.IntroductionConsumption of alcoholic beverages has beenlinked to a large number of health impairments,chronic diseases, and death worldwide.1 In 1988,
the International Agency for Research on Cancer (IARC)
established the carcinogenicity of alcoholic beverages,
based on an increased risk of liver cancer among
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Open access under CC BTwenty years later, the causal relationship with cancer
was established also for low and moderate alcohol
intakes, and at several additional sites.3,4 Alcohol con-
sumption causes cancers of the oral cavity; pharynx;
larynx; esophagus; colorectum; liver (hepatocellular car-
cinoma); and female breast. In addition, the IARC
Working Group concluded that ethanol in alcoholic
beverages is carcinogenic to humans (Group 1), and
acetaldehyde associated with the consumption of alco-
holic beverages is carcinogenic to humans (Group 1).
The role of ethanol metabolism in tumor initiation is
implied by the associations observed between different
forms of cancer and polymorphisms in genes involved in
the oxidation of ethanol. Whether, or to what degree,
these associations are explained by redox changes,
formation of radicals, effects on intermediary metabo-
lism, and/or effects on other pro-carcinogens cannot be
established from current ﬁndings. Concerning thelsevier Inc. on behalf of American Journal of Preventive Medicine
Y-NC-ND license.
Scoccianti et al / Am J Prev Mrelationship between alcohol consumption and breast
cancer, the underlying biological mechanisms are not
well deﬁned. Estrogens and androgens are well-known
activators of cellular proliferation, which is associated
with an increased risk of breast carcinogenesis. Alcoholic
beverage consumption in women causes an increase in
levels of endogenous estrogens, which has been suggested
to contribute to the development of breast cancer.
Alcohol dehydrogenase (ADH)–mediated alcohol oxida-
tion, which increases the hepatic redox state, which in
turn inhibits catabolism of sex steroids, has been
suggested as the mechanism for the alcohol-mediated
elevation in steroid levels.
Given the high prevalence of moderate alcohol drink-
ing among women in many populations,5 alcohol-related
breast cancer is an important public health issue. The
total percentage of alcohol-attributable breast cancer
cases is estimated at 5% (95% CI¼2%, 8%) among
women in eight European countries.6
At present, several aspects of the association of alcohol
consumption with breast cancer risk are not fully
elucidated. Since the most recent IARC Monograph,4
new studies have provided relevant information on issues
regarding the types of alcoholic beverages, the timing and
pattern of exposure, potential modifying factors, and
polymorphisms in genes involved in the mechanisms of
alcohol carcinogenesis (exempliﬁed in Figure 1 and
summarized in Table 1). In this review, the focus is on
the new available data, with background information on
the mechanisms of alcohol-related carcinogenesis.ALCOHOL
Ethanol, polyphenols, etc.
Acetaldehyde Acetate
DNA methylation
Hormonal pathway
Menopausal status
ADHs, ALDHs, GSTM1, GSTTs
Folate path
Alcohol intake, drinking habits, type of 
alcoholic beverages
Figure 1. Modifying factors involved in alcohol-related breas
representation of ethanol metabolism following alcohol intake
may modulate the association with the risk of female breast ca
March 2014Evidence Acquisition
The present review is an update of the most recent IARC
Monograph on alcoholic beverages.3 Since that report, new data
have become available and have been considered in this analysis.
The PubMed/MEDLINE search was restricted to publication dates
between November 2009 and January 2013 and to articles
published in English. Key words, alone or in combination,
included breast cancer, alcohol, binge drinking, menopausal status,
ER (estrogen receptor), PR (progesterone receptor), ADH, ALDH
(aldehyde dehydrogenase), GSTM1 and GSTT1 (glutathione-S-
transferases), BRCA (breast cancer–susceptibility gene), MTHFR
(methylenetetrahydrofolate reductase), and folate. References cited
by the relevant retrieved articles were also reviewed. In addition,
some studies on mechanisms of alcohol-related carcinogenesis
were included for background information.
Evidence Synthesis
The causal relationship between consumption of alco-
holic beverages and breast cancer risk is supported by
epidemiologic studies, and corroborated by animal and
in vitro evidence.3 Most cohort7–14 and case–control
studies15–20 reported a linear dose–response with increas-
ing daily or cumulative intake. For each additional
standard drink/day, breast cancer risk is estimated to
increase from 2% (relative risk [RR]=1.02, 95% CI=1.01,
1.03) up to 12% (RR=1.12, 95% CI=1.09, 1.14).8,21,22 The
most striking increase in risk is provided by the Million
Women Study, which performed an analysis of more
than 28,000 incident cases and reported a linear increase
in breast cancer risk with increasing alcohol consump-
ed 2014;46(3S1):S16–S25 S17Breast cancer
way
BRCA mutations
t carcinogenesis. Schematic
and of the main factors that
ncertion.21 Those few studies
that reported a nonsigniﬁ-
cant or null association
included a small number
of drinkers compared with
nondrinkers, lacked quan-
titative assessment of alco-
hol intake, or did not
adjust for potential con-
founders.23–25
Dimensions of
Alcohol Consumption
and Types of Alcoholic
Beverage
Dimensions of alcohol
consumption. Exposure to
alcohol is expressed either
in percentage by volume
(how many milliliters of
alcohol are present for every
100 mL of beverage at
201C) or in ethanol intake
Table 1. Breast cancer risk by dimensions of alcohol consumption and by main modifying factors
Dimensions of alcohol consumption Study; study design Exposure category Relative risk (95% CI) p for trend
Types of alcoholic beverage For 10 g/day
Allen (2009)21; cohort study Wine 1.10 (1.07, 1.14)
Other drinks 1.12 (1.09, 1.15)
Zhang (2007)7; WHS cohort study Beer 1.15 (1.03, 1.28) Not signiﬁcant
White wine 1.13 (1.00, 1.27)
Red wine 1.08 (0.88, 1.34)
Liquor 1.08 (0.98, 1.19)
Age at start drinking Liu (2012)40; Young adulthood (18–22 years)
NHS II cohort study None 1.00 (ref)
10 g/day 1.15 (1.03, 1.28)
Z15 g/day 1.35 (1.01, 1.81) 0.03
Occasional heavy drinking Chen (2011)36; NHS cohort study None 1.00 (ref)
1–2 drinks/day in a month 1.08 (1.02, 1.16)
3–5 drinks/day in a month 1.16 (1.07, 1.27)
Z6 drinks/day in a month 1.33 (1.11, 1.59) o0.001
Main modifying factors
Hormones expression For 10 g/day p for heterogeneity among studies, 0.09
Suzuki (2008)55; meta-analysis ERþ 1.12 (1.08, 1.15)
ERþPRþ 1.11 (1.07, 1.14)
ERþPR– 1.15 (1.02, 1.30)
ER– 1.07 (1.00, 1.14)
ER–PRþ 1.04 (0.76, 1.43)
ER–PR– 1.04 (0.98, 1.09)
Menopausal status For 10 g/day
Chen (2011)36; NHS cohort study Premenopausal 1.08 (1.00, 1.18)
Postmenopausal 1.07 (1.03, 1.10)
(continued on next page)
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March 2014(number of drinks per time-period, typically per day or per
week; one drink is equivalent to 10–12 g of pure ethanol).
Alcohol percentages by volume are typically 4%–5% for beer,
12% for wine, and 40% for distilled spirits; however, these
may vary widely. Ethanol content may range from 3% to
more than 10% in beer (home-brewed or locally produced
beers, such as sorghumbeer, exhibit a lower alcohol content),
from 8% to 15% in wine, and from 20% in aperitifs to 80% in
some types of absinthe.3 Most studies evaluate the average
volume of alcoholic beverage intake, possibly leading to bias
in assessing exposure, since the size and strength of each
drink are unknown.
The lack of a global harmonization in dimensions of
alcohol consumption prevents us from drawing ﬁrm
conclusions about safe levels of alcohol intake.21,26,27
Nevertheless, it has been recommended that women
should not exceed 1–2 drinks/day.28–30
Types of alcoholic beverage. Overall, the difference in
breast cancer risk between different types of alcoholic
beverage is not consistent and provides further evidence
that ethanol is the main causal factor.15,21 However,
spirits such as Calvados contain high concentrations of
the carcinogenic acetaldehyde31 and many compounds
present in various alcoholic beverages, such as nitros-
amines, may contribute to the development of breast
cancer. In contrast, phytochemicals contained in red
wine could act as protective factors on breast cancer
development.32 In experimental settings, these natural
phenolic compounds were shown to inhibit the activity
of aromatase or to alter DNA methylation after expo-
sure to ethanol.33,34 Further in vivo studies may con-
tribute to elucidating whether chemicals other than
ethanol contained in alcoholic beverages increase or
decrease the risk of breast cancer among alcohol
drinkers.
Age at start of drinking. Consumption of alcoholic
beverages as a risk factor for breast cancer may interact
with other breast cancer risk factors such as hormonal
status or ﬁrst full-term pregnancy,35,36 and thus differ-
entially modulate breast cancer risk over a woman’s
lifetime.37 A limited number of studies have investigated
the presence of a window of higher susceptibility to alcohol-
related carcinogenesis. In utero exposure of rats leads to an
increased frequency of malignant mammary tumors in
offspring.38,39 The Nurses’ Health Study (NHS)–II shows
that alcohol consumption during adolescence and early
adulthood is dose-dependently associated with an increased
risk of proliferative benign breast disease, which may lead
to invasive breast cancer later in life.40 Similar results are
observed at a higher drinking frequency and are consistent
with the hypothesis that alcohol carcinogens may
Scoccianti et al / Am J Prev Med 2014;46(3S1):S16–S25S20preferentially act during mammary development.41 ER-
positive cells and proliferative activities are at a peak during
puberty, and drinking during puberty could trigger a higher
risk of breast cancer than that observed for exposure later in
life.42 However, a detailed prospective analysis of the NHS
study and of a large Danish cohort of postmenopausal
women could not conﬁrm a difference in risk according to
age at start drinking.36,43 Poor information on age at start
drinking, recall bias in early lifetime compared with adult-
hood, and failure to assess alcohol intake throughout the
lifetime in some studies, may partially explain the discrep-
ancy between studies. Overall, these ﬁndings support the
hypothesis that timing of exposure to alcohol carcinogens
affects breast tumorigenesis, without however enabling the
identiﬁcation of a window of higher susceptibility. Epide-
miologic studies need to provide more comprehensive
information on age at start drinking and to precisely assess
alcohol intake throughout the lifetime, in light of the
important implication in terms of breast cancer prevention.
Occasional heavy drinking. The occasional consumption
of Z60 g of pure alcohol on at least one occasion in the
past 7 days44 is a drinking pattern known as binge
drinking. This type of excessive drinking is increasing
particularly among adolescents and young adults of both
genders in high-income countries, and creates consider-
able public health concern and safety problems.45–47 The
CDC reported that, in the U.S., about 22% of adolescents
engage in binge drinking behavior and that female binge
drinkers consume more alcohol overall than other
women.8 The Nurses’ Health Study reported that female
binge drinkers had an increased RR for breast cancer of
1.33 (95% CI¼1.11, 1.59) compared with other women.36
Binge drinking is a relatively new habit among young
women and those few studies exploring such drinking
patterns have not yet adopted standardized measure of
exposure, thus making comparison of available results
difﬁcult. Moreover, reporting bias of actual consumption
is likely to be more important in epidemiologic studies on
binge drinking, since excessive drinking is more likely to
be intentionally underreported by participants.48
Main Effect Modiﬁers
The leading pathway of ethanol metabolism takes place
mainly in the liver where ethanol is oxidized to acetalde-
hyde, a process catalyzed by ADH and cytochrome P450
2E1 enzymes. Ethanol metabolism may also lead to
reactive lipid peroxides, free radicals, and other cytotoxic
products, which are detoxiﬁed by GSTM1 and GSTT1
enzymes. Acetaldehyde is further converted to the non-
carcinogenic acetate by ALDH enzymes. A large portion of
ingested ethanol reaches the bloodstream, and may
distribute into the breast and be converted to acetaldehydeby ADH enzymes expressed in the breast tissue.49 Ace-
taldehyde is capable of inducing DNA strand deletions,
chromosomal aberrations, and generating protein and
DNA adducts.50 Both ethanol and acetaldehyde interfere
with estrogen pathways and may trigger the expression of
hormone receptors (e.g., estrogen, prolactin receptors) in
breast tumors,51 thus modulating the risk according to
hormone receptor expression and menopausal status.
Hormone-dependent breast cancer subtypes. Ethanol
stimulates both cell proliferation and the transcriptional
activity of liganded ER, which in turn increases levels of
circulating estrogens that control proliferation and mor-
phogenesis in the breast.52–54 The major clinical breast
cancer subtypes, classiﬁed according to the presence or
absence of hormone receptor expression, are luminal A
(ERþ and/or PRþ, human epidermal growth factor
receptor 2 [Her2] negative), luminal B (ERþ and/or
PRþ, Her2þ), Her2þ (ER–, PR–, Her2þ), basal-like or
triple negative (ER–, PR–, Her2–), and normal breast-like.
Most studies observe an overall stronger association with
ERþ and/or PRþ tumors compared with ER– and/or PR–
tumors, for the highest versus the lowest alcohol consump-
tion group.7,12,55–58 In a meta-analysis, Suzuki and col-
leagues59 reported a 12% increase in risk of ERþ tumors for
each additional drink, a smaller positive association (7%
increase in risk) with all ER– tumors, and no association
with ER–/PR– or ER–/PRþ tumors when taken separately.
Barnes and colleagues60 noted an inverse relationship
between alcohol consumption and risk of ER–/PR– tumors.
A recent study found a stronger positive association for
alcohol-related luminal A or Her2þ overexpressing tumors
compared with other subtypes; however, for these rarer
subtypes data are still limited.61 Together these results
indicate that alcohol consumption increases breast cancer
risk by inducing the expression of ER and PR hormone
receptors.62 Nevertheless, the estrogen-dependent pathway
cannot solely explain the positive association between
alcohol consumption and ER tumors, and the underlying
biological mechanisms need further clariﬁcation.
Menopausal status. A different association of breast
cancer risk with alcohol drinking among pre- and post-
menopausal women has been frequently advocated
because the large majority of breast cancers, and in
particular those occurring after menopause, are hormone-
dependent.63 Elevated levels of endogenous sex hormones
have been repeatedly associated with an increased risk of
breast cancer.7,64–66 Postmenopausal women who use
hormone replacement therapy (estrogen plus progestin)
show a signiﬁcant increase in risk of breast cancer
(RR=2.24, 95% CI=1.59, 3.14) compared with those
who do not, for a daily consumption of at least 20 g ofwww.ajpmonline.org
Scoccianti et al / Am J Prev Med 2014;46(3S1):S16–S25 S21alcohol.67 However, despite abundant epidemiologic
research, overall the trends in alcohol-related breast
cancer risk are similar for pre- and post-menopausal
women. For a moderate daily alcohol intake (i.e., 10–20 g),
relative risks range from 0.97 (95% CI¼0.23, 4.06) to 2.07
(95% CI¼1.57, 4.66) in postmenopausal women, versus
0.85 (95% CI¼0.31, 2.34) to 1.66 (95% CI¼0.90, 3.05) in
premenopausal women.7,20,36,55,68 At present, the available
evidence does not show that menopausal status alone is a
signiﬁcant modiﬁer of the association between alcohol
consumption and breast cancer.7,8,25,56,69
Polymorphisms in Genes Involved in Ethanol
Metabolism and Detoxiﬁcation
Genes regulating alcohol metabolism. Polymorphisms
in genes that regulate acetaldehyde formation and
detoxiﬁcation may confer an individual susceptibility to
breast cancer by altering the rates of ethanol oxidation
and of acetaldehyde elimination in the bloodstream.
In one study in Germany, the ADH1B*2 allele showed a
protective effect on alcohol-related breast cancer risk.70 In
four other studies in Japan, the United Kingdom, and the U.
S., however, no signiﬁcant differences in the risk by ADH1B
polymorphism were observed.56,69,71,72 No signiﬁcant asso-
ciation with the *5B/*5B genotype73,74 or the ALDH2
mutation,74,75 which leads to low degradation of acetalde-
hyde, have been reported. The enzyme ADH1C is a member
of the ADH family; the *1/*1 polymorphic variant induces a
2.5-fold higher rate of ethanol oxidation and confers a 1.8
times higher breast cancer risk compared with wild-type
allele, likely due to a prolonged exposure to acetaldehyde.76,77
In some studies, the association was more pronounced
among premenopausal women,78 or among regular heavy
drinkers,56 but these results were not always replicated.69,79 In
addition, recent meta-analyses failed to show an increased
risk of breast cancer in ADH1C *1/*1 allele carriers either in
Caucasian or in Chinese populations.77,80 Carriers of
GSTM1A and GSTT1-null genotypes fail to detoxify the
toxic metabolites of ethanol. Postmenopausal carriers of the
GSTT1-null genotype who consume more than 150 g/day of
spirit-equivalents showed a substantial increase in risk of
breast cancer (OR=3.1, 95% CI=0.6, 15.1) compared with
their wild-type counterpart.81 However, recent ﬁndings do
not fully support a protective role of the GST isoenzymes on
alcohol-related breast cancer risk.82
One possible explanation for the lack of consistency in
results between polymorphisms involved in ethanol
metabolism and breast cancer risk is that studies showing
a positive association reported on subjects with high
regular alcohol consumption.
Folate and MTHFR interaction. Folate (the B-vitamin) is
involved in a number of metabolic pathways central to theMarch 2014one-carbon metabolism pathway, DNA synthesis, and cell
replication. Folate deﬁciency leads to misincorporation of
uracil, chromosomal instability, and DNA hypomethyla-
tion, causing altered gene expression and thus contributing
to cancer development.83 Exposure to alcohol may dereg-
ulate the metabolism and levels of folate depending on
polymorphic variants of enzymes involved in one-carbon
metabolism.9,84–86 In heavy and regular alcohol drinkers,
increased degradation of vitamin B, or folate deﬁciency,
are reported, most likely because of a folate-poor diet and
to intestinal malabsorption, decreased liver uptake, and
increased urinary excretion of folic acid.87 Several cohort
studies report that high blood folate levels may play a
protective role on breast cancer risk related to alcohol
consumption,7,41,88 in particular among postmenopausal
women.89 The systematic review of the World Cancer
Research Fund on nutrition provides further evidence that
folate may prevent the carcinogenic action of ethanol
in breast tissue.90 On the other hand, some studies report
that the protective effect of high folate intake is either
null7–9,12,25,56,69,91; limited to women with high alcohol
consumption (Z4 drinks/day)92; or inversed among pre-/
peri-menopausal ERþ women.64,65 Folate studies indeed
face a multiplicity of challenges, such as inaccurate
estimates of folate intake (based on food composition data
or self-administered questionnaires instead of serum or
whole blood content); recall bias; and confounding (such
as healthier behaviors or low alcohol drinking among
women with an adequate folate intake).
Most of the genes involved in the one-carbon meta-
bolic pathway are polymorphic in nature and may
modulate an individual’s interaction with dietary folate
intake. The MTHFR gene is the best studied for cancer
susceptibility.93,94 MTHFR synthesizes the major carbon
donor in the remethylation of homocysteine to methio-
nine, and epigenetic deregulation might play a key role in
the initiation and progression of breast cancer among
drinkers.95–98 The effect modiﬁcation of the 677T poly-
morphism on breast cancer development99,100 is
observed in particular after menopause.85,86 Individuals
homozygous for the MTHFR 677T variant show
increased breast cancer risk at more than 2 drinks/day
compared with nondrinkers.94 Several studies reported
that dietary folate may modulate breast cancer risk
through aberrant DNA methylation during the early
stages of mammary gland development.95,96 Also, breast
cancer MTHFR 677T cells showed genomic DNA hypo-
methylation, a characteristic of most cancers, when folate
supply was adequate or high.101
BRCA1/BRCA2 and Hereditary Breast Cancer
The BRCA1 and BRCA2 genes help to ensure DNA
stability and to prevent uncontrolled cell growth in wild-
Scoccianti et al / Am J Prev Med 2014;46(3S1):S16–S25S22type cells.102 These high-penetrance genes play a key role
in hereditary breast cancer; however, their potential effect
on the association with other risk factors such as alcohol
consumption is still controversial. BRCA1 is a potent
inhibitor of ERα activity and ethanol both down-regulates
the gene’s expression and enhances the receptor’s func-
tion.103 The available evidence does not show an increased
risk of breast cancer related to alcohol consumption
among BRCA1 carriers, although it suggests a decreased
risk among BRCA2 carriers (OR¼0.41, 95% CI¼0.22,
0.77) associated with a modest alcohol intake.104,105 Over-
all, the evidence is still limited because of the small number
of study subjects. Nevertheless, further studies elucidating
the contribution of environmental determinants to heredi-
tary breast cancer could have major implications for
cancer prevention in high-risk families.
Conclusion
Recent publications add to the current body of evidence
that consumption of alcoholic beverages is causally
associated to cancer of the female breast, even at low
levels of alcohol consumption.
Current data indicate that breast cancer risk does not
vary by beverage type and strengthen the evidence that
ethanol is the main causal factor; nevertheless, other
compounds present in various alcoholic beverages may
play a role in, or prevent, the development of breast
cancer. Polymorphisms in genes involved in the forma-
tion and detoxiﬁcation of ethanol metabolites are known
to modulate the risk of cancer at other sites, and could
modulate the association of alcohol consumption with
breast cancer risk; however, at present, results are
controversial and do not allow the identiﬁcation of
susceptibility alleles for breast cancer subtypes. Exper-
imental and epidemiologic studies show that alcohol-
induced breast cancer may be related to an enhanced
responsiveness to ER, thus suggesting that the association
may be stronger for exposure during adolescence and
early adulthood. In addition, there is growing evidence of
an environmental impact on the breast cancer epigenome
through nutrition. The MTHFR polymorphism appears
to play a role via a folate-dependent epigenetic mecha-
nism also modiﬁed by ethanol and possibly by meno-
pausal status. However, the precise targets of epigenetic
deregulation in breast cancer are still unclear; the ﬁeld is
rapidly expanding and additional data may allow the
identiﬁcation of speciﬁc methylation signatures.
Future Perspective
Better standardization in measuring the amount of
alcohol intake and drinking pattern, improved knowl-
edge of the relevant window of exposure, information onthe presence of genetic polymorphisms modulating the
effects of alcohol, and the estimation of the interaction of
alcohol with nutrients such as folate will prove extremely
valuable in terms of breast cancer prevention. Such
information will improve our understanding of the
mechanisms by which alcohol consumption increases
breast cancer risk and of the heterogeneity observed
across studies; thus also allowing to more accurately
estimate breast cancer risk at different age stages, and to
quantify the effect of hazardous drinking patterns.
Understanding individual attitudes toward alcohol
drinking and the inﬂuence of cultural and social factors
will improve our assessment of the impact of alcohol
drinking to tailor public health messages toward most
susceptible population subgroups.
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